View Exam | PowerPak

1. AJ's diagnosis is best classified as: CASE STUDY 1-11

A. Excessive daytime sleepiness (EDS) B. Narcolepsy type 1 (NT1) C. Narcolepsy type 2 (NT2) D. Idiopathic hypersomnia E. Unsure

2. Which feature or symptom of narcolepsy is present in AJ?

A. Cataplexy B. Fragmented nighttime sleep C. Autonomic disturbances D. Weight gain E. Unsure

3. Which of the following is the most likely etiology of AJ's condition?

A. Family history B. Puberty C. Influenza D. Levonorgestrel/ethinyl estradiol E. Unsure

4. Which medication would be most appropriate to initiate for AJ at this time?

A. Venlafaxine B. Methylphenidate C. Sodium oxybate D. Modafinil E. Unsure

5. What counseling point is important to provide AJ regarding her new narcolepsy medication?

A. Full effects of the medication may not be evident for several weeks to months B. Her oral contraceptive must have at least 0.04 mg ethinyl estradiol to be effective C. By law, no refills are allowed, and she must obtain a new prescription for every fill D. She should follow a sodium-restricted diet E. Unsure

6. During follow-up visits, which test is the most appropriate for monitoring the effectiveness of treatment in a patient like AJ?

A. Multiple Sleep Latency Test (MSLT) B. Narcolepsy Severity Scale (NSS) C. CSF hypocretin-1 levels D. Maintenance of Wakefulness Test (MWT) E. Unsure

7. CASE update:
AJ is treated for her narcolepsy for 2 years with her initial therapy: she takes the maximum recommended dose twice daily. At a routine follow-up, she has a mean sleep onset of 8 minutes and an ESS score of 15. She does not report any new symptoms or features of narcolepsy, but she states that she feels the duration of the medication's effects has waned over the past several months.

Which of the following is the most appropriate treatment strategy for AJ at this time, according to her medication assessment and follow-up symptom severity scores?

A. Add clomipramine to her current regimen B. Discontinue current therapy and initiate methylphenidate C. Add solriamfetol to her current regimen D. Discontinue current therapy and initiate armodafinil E. Unsure

8. If AJ's treatment team wants to prescribe a non-controlled substance, which of the following could be used to treat her narcolepsy?

A. Sodium oxybate B. Solriamfetol C. Pitolisant D. Armodafinil E. Unsure

9. CASE update:
At age 25, approximately 6 years after her initial narcolepsy diagnosis, AJ presents with new symptoms. AJ and her family report repeated, sudden, and transient episodes of bilateral facial droop over the past 4 months that were not associated with episodes of EDS. AJ has recently completed graduate school and started a new job. Her current ESS score is 7 and she states that she feels her EDS is controlled on her current therapy. She is most concerned about the impact these new episodes are having on her daily life, her ability to perform at work, and her overall health.

Which of the following best describes what AJ is experiencing?

A. A medication-induced adverse effect B. A stroke C. Progression from NT2 to NT1 D. Development of tolerance to her current narcolepsy regimen E. Unsure

10. On the basis of her current clinical presentation, what addition to AJ's narcolepsy therapy is appropriate at this time?

A. Amphetamine/dextroamphetamine B. Solriamfetol C. Sodium oxybate D. Venlafaxine E. Unsure

Evaluation Questions

11. How confident are in your treatment choices for AJ in above questions:

A. Not at all confident B. Somewhat confident C. Confident D. Highly confident

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. AJ's diagnosis is best classified as: CASE STUDY 1-11

2. Which feature or symptom of narcolepsy is present in AJ?

3. Which of the following is the most likely etiology of AJ's condition?

4. Which medication would be most appropriate to initiate for AJ at this time?

5. What counseling point is important to provide AJ regarding her new narcolepsy medication?

6. During follow-up visits, which test is the most appropriate for monitoring the effectiveness of treatment in a patient like AJ?

8. If AJ's treatment team wants to prescribe a non-controlled substance, which of the following could be used to treat her narcolepsy?

10. On the basis of her current clinical presentation, what addition to AJ's narcolepsy therapy is appropriate at this time?

Evaluation Questions

11. How confident are in your treatment choices for AJ in above questions:

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. AJ's diagnosis is best classified as: CASE STUDY 1-11

2. Which feature or symptom of narcolepsy is present in AJ?

3. Which of the following is the most likely etiology of AJ's condition?

4. Which medication would be most appropriate to initiate for AJ at this time?

5. What counseling point is important to provide AJ regarding her new narcolepsy medication?

6. During follow-up visits, which test is the most appropriate for monitoring the effectiveness of treatment in a patient like AJ?

8. If AJ's treatment team wants to prescribe a non-controlled substance, which of the following could be used to treat her narcolepsy?

10. On the basis of her current clinical presentation, what addition to AJ's narcolepsy therapy is appropriate at this time?

Evaluation Questions

11. How confident are in your treatment choices for AJ in above questions:

« Return to Activity

Customers who Purchased
this Activity also Purchased